|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 677.10 USD | +0.06% |
|
+2.39% | -12.04% |
| 02:05pm | Goldman Sachs Adjusts Price Target on Regeneron Pharmaceuticals to $965 From $968, Maintains Buy Rating | MT |
| 07-16 | Merck gets US FDA nod for first-in-its-class oral cholesterol drug | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Neutral |
| Resistance | 686.36 | 686.36 | 803.17 |
| Spread/Res. | -1.08% | -1.08% | -15.47% |
| Spread/Supp. | +6.84% | +13.03% | +21.24% |
| Support | 635.45 | 600.66 | 560 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- REGN Stock
- Charts Regeneron Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
